(UroToday.com) As part of the Master Class session on genomic testing and recurrence in prostate cancer at the 2020 Société Internationale d’Urologie (SIU) virtual annual meeting, Dr. Shusuke Akamatsu discussed liquid biopsy in prostate cancer.
Dr. Akamatsu started by outlining the landscape of advanced prostate cancer, starting with Dr. Huggins innovating surgical castration in 1941 through olaparib being approved in 2020: